Clinical trials: ABO Incompatibility
COVID-19, Blood Group Antigen Abnormality
ABO Blood Group Type Association With COVID-19 Severity
The COVID-19 pandemic has caused a significant healthcare burden and remains a heavily researched disease entity. Originating in Wuhan, China in late 2019, SARS-CoV-2 has infected over 600 million individuals worldwide.
- Conditions
- COVID-19, Blood Group Antigen Abnormality, Blood Group Incompatibilities, Diabetes Mellitus
- Trial name
- NCT05859958
- Testing
- No Intervention
- Where
- United States
- Volunteers
- 599 people, healthy volunteers welcome
- Sponsor
- Arrowhead Regional Medical Center
Rh Incompatibility Reaction
Development a Rhesus Type Compatibility Test by Means of an Antibody Able to Recognize RH1 Antigen Grafted on a Biochip
Every year, several millions of red cell concentrates are transfused. For each of them, a pretransfusional compatibility test is performed.
- Trial name
- ABORDAGE (NCT02857075)
- Testing
- Blood donation
- Volunteers
- 45 people, healthy volunteers welcome
- Sponsor
- Centre Hospitalier Universitaire de Besancon
Newborn Jaundice, Hyperbilirubinemia, Neonatal
White Cover & Massage Effects on Bilirubin and Phototherapy in ABO-Incompatible Newborns
This study aims to examine the effect of white cover and massage application on bilirubin levels and phototherapy duration in newborns with ABO incompatibility receiving phototherapy.
- Conditions
- Newborn Jaundice, Hyperbilirubinemia, Neonatal, ABO Incompatibility, Newborn Massage
- Trial name
- NCT06921330
- Testing
- white cover-newborn massage
- Where
- Turkey (Türkiye)
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Karabuk University